Finoriq

Finoriq research workspace

ARTIVION, INC. (AORT) Company Overview

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues. Review AORT filings, fundamentals, valuation, and ownership on Finoriq.

Company Snapshot

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers On-X prosthetic aortic and mitral heart valves; On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters; Chord-X ePTFE sutures; pyrolytic carbon coating services; E-vita Open NEO, a hybrid stent graft; Arcevo, an LSA hybrid stent graft system; AMDS hybrid prosthesis; and NEXUS ONE, an endovascular stent graft system. It also provides NEXUS DUO, an aortic arch system; NEXUS TRE, a custom-made three branch graft; E-vita thoracic 3G, a stent graft system; E-xtra Design Engineering, a range of stent graft systems for the treatment of aortic vascular diseases, such as TAAA and Artivex; E-nside, a multibranch stent graft system; E-tegra, an AAA stent graft system; E-ventus BX and Tuva BX balloon-expandable peripheral stent grafts; and E-liac, a stent graft used to treat aneurysmal iliac arteries. In addition, the company offers synthetic vascular grafts that are used in open aortic and peripheral vascular surgical procedures; BioGlue, a surgical sealant; CryoValve SG pulmonary heart valve; CryoPatch SG pulmonary cardiac patch; SynerGraft, a decellularization technology; vascular preservation services; and PhotoFix, a bovine pericardial patch fixated. It markets its products and preservation services primarily to physicians through a direct sales team to hospitals and other healthcare facilities. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.

Company
ARTIVION, INC. (AORT)
Ticker
AORT
Market Cap
$1.2B
Latest Price
$25.65
Industry
Medical Devices

Open insider transactions

ARTIVION, INC. (AORT) Current Valuation Metrics

Static valuation preview for ARTIVION, INC. (AORT). Market data retrieved 2026-07-08. Filing currency USD.

MetricValueSource
P/EMarket cap divided by latest TTM net income.98.4xNet Income | TTM Q1 2026
P/SMarket cap divided by latest TTM revenue.2.51xRevenue | TTM Q1 2026
P/Operating Cash FlowMarket cap divided by latest TTM operating cash flow.19.8xOperating Cash Flow | TTM Q1 2026
Earnings YieldLatest TTM net income divided by market cap.1.0%Net Income | TTM Q1 2026
Operating Cash Flow YieldLatest TTM operating cash flow divided by market cap.5.0%Operating Cash Flow | TTM Q1 2026

Live data loads in the app

This static page shell gives search engines reliable page context. Current tables, filings, charts, and market data continue to load from Finoriq APIs after the application starts.